Published On: Mon, Dec 14th, 2015

Nurofen owner Reckitt Benckiser ordered to stop selling ‘misleading’ painkillers

Consumers were being tricked into thinking four products were designed to treat a specific type of pain



An Australian court has ordered Nurofen’s UK owner to stop selling several versions of the popular painkiller that were identical to its standard ibuprofen pills, but nearly twice as expensive.

The Federal Court ruled that British consumer goods company Reckitt Benckiser deceived Australians by selling Nurofen painkillers that were marketed to relieve specific ailments, such as back pain, but all of the products contained an identical amount of the same active ingredient, ibuprofen lysine.

Read the full story at The Independent, by Jason Reed

Read more about: , , , ,

About the Author

Wordpress site Developed by Fixing WordPress Problems